Smoothing cost variations on the medical side
Optum MedicalRx Specialty Provider Network helps plan sponsors control the cost of specialty drugs by standardizing fair market-value reimbursement rates for providers within the network. The solution saves plan sponsors $1.38 per member per month.4
What you can expect from Optum specialty pharmacy
We are your specialty pharmacy partner and have a shared purpose to help manage the costs of specialty medications while ensuring members get the medications they need. We do this by focusing on four key strengths.
1. Proven pharmacy management
This is foundational to any specialty strategy, and it’s what makes our cross-benefit approach so powerful. Helping plan sponsors manage utilization, avoid waste and take full advantage of market trends, that’s just the start of your savings opportunities.
2. Pharmacy care and clinical expertise
The people we serve are at the center of specialty medication management. Leveraging our analytics, technology, and clinical resources, we personalize care, collaborate with providers and help ease access for members.
3. Innovative medical management
Sometimes the most effective drug management is on the medical benefit. Aligning medical and pharmacy specialty management so closely has led to $16 PMPM savings on specialty drug spend and MedicalRx Rebates alone has reduced costs by $7.80 - $8.40 PMPM.
4. Aggressive cross-benefit management
Optum has the pharmacy and medical footprint, data and expertise to help plan sponsors and providers make more precise specialty decisions based on whichever benefit offers the greatest clinical and cost advantage.
Featured insights
Gene therapies: Can we afford the future of medicine?
Learn how to manage financial risk as gene therapies become more commonplace.
How to manage blockbuster anti-obesity drugs
The pricey weight management drugs work well, but users need coaching and support to maintain the benefits.
The next biosimilar wave has arrived. Now what?
In this conversation, learn about a new class of biosimilars and what this means for competition, cost and volume in the PBM market.
- Specialty savings book of business April 2021 on a standalone basis, not tied to the medical carrier.
- Clinical interventions: Optum Patient Exchange Intervention Tool, Book of Business, 8/1/20-7/31/21, Generic conversion: Optum Specialty Pharmacy BOB Data 7/1/2021 – 8/24/2022.
- Optum Specialty Pharmacy Patient Assistance Active Grant Report and Optum copay card assistance totals report, 2023.
- Optum internal analysis based on 18.5 million commercial lives from Jan. 1, 2019 to Sept. 3, 2020.